What Does Omeros Corporation Do?

Total employees237
HeadquartersSeattle
Founded1994

Omeros Corporation is a commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market and orphan indications. The company's research and development efforts primarily target inflammation, complement-mediated diseases (focusing on its MASP-2 inhibitor narsoplimab and MASP-3 inhibitor OMS1029), and disorders of the central nervous system. Omeros also has a proprietary G protein-coupled receptor (GPCR) platform, GPR174, with potential applications in immuno-oncology. The company previously marketed OMIDRIA® for use during cataract surgery or intraocular lens replacement.

Where Is Omeros Corporation's Headquarters?

HQ Function

The headquarters serves as the central hub for Omeros's research and development, clinical operations, corporate strategy, finance, and administrative functions.

Notable Features:

Located in the Lower Queen Anne neighborhood, the office building offers modern facilities and proximity to other technology and biotech companies. Specific architectural highlights are not widely publicized, but it is designed to support collaborative and innovative work.

Work Culture:

The work culture at Omeros's Seattle headquarters is characterized by a strong focus on scientific innovation, collaboration across multidisciplinary teams, and a dedication to addressing unmet medical needs. The environment is often fast-paced, driven by research milestones and clinical development timelines typical of the biopharmaceutical industry.

HQ Significance:

Its Seattle location strategically places Omeros within a vibrant ecosystem of research institutions (like the University of Washington and Fred Hutchinson Cancer Research Center), biotech companies, and a skilled talent pool, fostering opportunities for collaboration and innovation.

Values Reflected in HQ: The headquarters' setup aims to reflect Omeros's commitment to scientific excellence, innovation, and efficient operations, providing an environment conducive to advancing its drug development programs.

Location:

While Omeros Corporation's primary operations and headquarters are based in Seattle, USA, its impact and activities, particularly in clinical development, regulatory affairs, and potential future commercialization, have a global scope. The company conducts clinical trials that often involve sites in multiple countries and collaborates with international partners, CROs, and CMOs to advance its therapeutic programs. Its engagement with regulatory bodies like the FDA (US), EMA (Europe), and others inherently involves a global perspective on drug development and approval standards.

Street Address:

201 Elliott Avenue West

City:

Seattle

State/Province:

WA

Country:

USA

Where Else Does Omeros Corporation Operate Around the World?

Not Publicly Disclosed

Address: Not Publicly Disclosed

The company's strategy appears focused on a centralized headquarters model, leveraging global partnerships, contract research organizations (CROs), and contract manufacturing organizations (CMOs) for broader operational reach rather than maintaining numerous physical international offices.

Buying Intent Signals for Omeros Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Omeros Corporation? Meet the Executive Team

As of April 2025, Omeros Corporation' leadership includes:

Gregory A. Demopulos, M.D. - Chairman, President and Chief Executive Officer
Thomas R. Buba, Ph.D. - Chief Financial Officer
Michael A. Jacobsen - Chief Accounting Officer, Treasurer and Secretary
J. Steven Whitaker, M.D., J.D. - Vice President, Clinical Development and Chief Medical Officer
Nadia Dac - Chief Commercial Officer
Peter B. Cancelmo, J.D. - General Counsel

Who's Investing in Omeros Corporation?

Omeros Corporation has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Renaissance Technologies LLC
Geode Capital Management, LLC

What Leadership Changes Has Omeros Corporation Seen Recently?

Hire2
Exits1

Over the last 12 months, Omeros Corporation appointed a new Chief Financial Officer and a Vice President of Regulatory Affairs and Quality. There was also a departure in a commercial leadership role.

Departures

Daniel M. Kirby, Pharm.D., Daniel M. Kirby departed from his role as VP, Head of Commercial, where he was involved in pre-launch activities for narsoplimab.

New Appointments:

Thomas R. Buba, Ph.D., Dr. Thomas R. Buba was appointed as the new Chief Financial Officer for Omeros Corporation.
Catherine A. Melfi, Ph.D., Dr. Catherine A. Melfi joined Omeros as Vice President, Regulatory Affairs and Quality.

What Technology (Tech Stack) Is Used byOmeros Corporation?

Discover the tools Omeros Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Omeros Corporation Email Formats and Examples

Omeros Corporation likely utilizes standard corporate email formatting conventions. The most common patterns typically involve a combination of the employee's first name, last name, or initials followed by the @omeros.com domain.

[first_initial][last]@omeros.com

Format

gdemopulos@omeros.com

Example

85%

Success rate

What's the Latest News About Omeros Corporation?

Omeros Corporation Investor RelationsMay 9, 2024

Omeros Corporation Reports First Quarter 2024 Financial Results

Omeros Corporation announced its financial results for the first quarter ended March 31, 2024. The company provided updates on its narsoplimab program for HSCT-TMA, its OMS906 program for paroxysmal nocturnal hemoglobinuria (PNH), and other pipeline developments....more

Omeros Corporation Investor RelationsApril 1, 2024

Omeros Announces Publication of Manuscript Detailing Discovery and Characterization of Narsoplimab Binding Site on MASP-2

Omeros Corporation announced the publication of a peer-reviewed manuscript in the journal *Protein Science*. The article details the discovery and characterization of the specific binding site of narsoplimab on MASP-2, its target lectin pathway enzyme, providing further insight into the drug's mechanism of action....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Omeros Corporation, are just a search away.